The neurodevelopmental and facial phenotype in individuals with a TRIP12 variant
Standard
The neurodevelopmental and facial phenotype in individuals with a TRIP12 variant. / Aerden, Mio; Denommé-Pichon, Anne-Sophie; Bonneau, Dominique; Bruel, Ange-Line; Delanne, Julian; Gérard, Bénédicte; Mazel, Benoît; Philippe, Christophe; Pinson, Lucile; Prouteau, Clément; Putoux, Audrey; Tran Mau-Them, Frédéric; Viora-Dupont, Éléonore; Vitobello, Antonio; Ziegler, Alban; Piton, Amélie; Isidor, Bertrand; Francannet, Christine; Maillard, Pierre-Yves; Julia, Sophie; Philippe, Anais; Schaefer, Elise; Koene, Saskia; Ruivenkamp, Claudia; Hoffer, Mariette; Legius, Eric; Theunis, Miel; Keren, Boris; Buratti, Julien; Charles, Perrine; Courtin, Thomas; Misra-Isrie, Mala; van Haelst, Mieke; Waisfisz, Quinten; Wieczorek, Dagmar; Schmetz, Ariane; Herget, Theresia; Kortüm, Fanny; Lisfeld, Jasmin; Debray, François-Guillaume; Bramswig, Nuria C; Atallah, Isis; Fodstad, Heidi; Jouret, Guillaume; Almoguera, Berta; Tahsin-Swafiri, Saoud; Santos-Simarro, Fernando; Palomares-Bralo, Maria; López-González, Vanesa; Kibaek, Maria; Tørring, Pernille M; Renieri, Alessandra; Bruno, Lucia Pia; Õunap, Katrin; Wojcik, Monica; Hsieh, Tzung-Chien; Krawitz, Peter; Van Esch, Hilde.
In: EUR J HUM GENET, Vol. 31, No. 4, 04.2023, p. 461-468.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - The neurodevelopmental and facial phenotype in individuals with a TRIP12 variant
AU - Aerden, Mio
AU - Denommé-Pichon, Anne-Sophie
AU - Bonneau, Dominique
AU - Bruel, Ange-Line
AU - Delanne, Julian
AU - Gérard, Bénédicte
AU - Mazel, Benoît
AU - Philippe, Christophe
AU - Pinson, Lucile
AU - Prouteau, Clément
AU - Putoux, Audrey
AU - Tran Mau-Them, Frédéric
AU - Viora-Dupont, Éléonore
AU - Vitobello, Antonio
AU - Ziegler, Alban
AU - Piton, Amélie
AU - Isidor, Bertrand
AU - Francannet, Christine
AU - Maillard, Pierre-Yves
AU - Julia, Sophie
AU - Philippe, Anais
AU - Schaefer, Elise
AU - Koene, Saskia
AU - Ruivenkamp, Claudia
AU - Hoffer, Mariette
AU - Legius, Eric
AU - Theunis, Miel
AU - Keren, Boris
AU - Buratti, Julien
AU - Charles, Perrine
AU - Courtin, Thomas
AU - Misra-Isrie, Mala
AU - van Haelst, Mieke
AU - Waisfisz, Quinten
AU - Wieczorek, Dagmar
AU - Schmetz, Ariane
AU - Herget, Theresia
AU - Kortüm, Fanny
AU - Lisfeld, Jasmin
AU - Debray, François-Guillaume
AU - Bramswig, Nuria C
AU - Atallah, Isis
AU - Fodstad, Heidi
AU - Jouret, Guillaume
AU - Almoguera, Berta
AU - Tahsin-Swafiri, Saoud
AU - Santos-Simarro, Fernando
AU - Palomares-Bralo, Maria
AU - López-González, Vanesa
AU - Kibaek, Maria
AU - Tørring, Pernille M
AU - Renieri, Alessandra
AU - Bruno, Lucia Pia
AU - Õunap, Katrin
AU - Wojcik, Monica
AU - Hsieh, Tzung-Chien
AU - Krawitz, Peter
AU - Van Esch, Hilde
N1 - © 2023. The Author(s), under exclusive licence to European Society of Human Genetics.
PY - 2023/4
Y1 - 2023/4
N2 - Haploinsufficiency of TRIP12 causes a neurodevelopmental disorder characterized by intellectual disability associated with epilepsy, autism spectrum disorder and dysmorphic features, also named Clark-Baraitser syndrome. Only a limited number of cases have been reported to date. We aimed to further delineate the TRIP12-associated phenotype and objectify characteristic facial traits through GestaltMatcher image analysis based on deep-learning algorithms in order to establish a TRIP12 gestalt. 38 individuals between 3 and 66 years (F = 20, M = 18) - 1 previously published and 37 novel individuals - were recruited through an ERN ITHACA call for collaboration. 35 TRIP12 variants were identified, including frameshift (n = 15) and nonsense (n = 6) variants, as well as missense (n = 5) and splice (n = 3) variants, intragenic deletions (n = 4) and two multigene deletions disrupting TRIP12. Though variable in severity, global developmental delay was noted in all individuals, with language deficit most pronounced. About half showed autistic features and susceptibility to obesity seemed inherent to this disorder. A more severe expression was noted in individuals with a missense variant. Facial analysis showed a clear gestalt including deep-set eyes with narrow palpebral fissures and fullness of the upper eyelids, downturned corners of the mouth and large, often low-set ears with prominent earlobes. We report the largest cohort to date of individuals with TRIP12 variants, further delineating the associated phenotype and introducing a facial gestalt. These findings will improve future counseling and patient guidance.
AB - Haploinsufficiency of TRIP12 causes a neurodevelopmental disorder characterized by intellectual disability associated with epilepsy, autism spectrum disorder and dysmorphic features, also named Clark-Baraitser syndrome. Only a limited number of cases have been reported to date. We aimed to further delineate the TRIP12-associated phenotype and objectify characteristic facial traits through GestaltMatcher image analysis based on deep-learning algorithms in order to establish a TRIP12 gestalt. 38 individuals between 3 and 66 years (F = 20, M = 18) - 1 previously published and 37 novel individuals - were recruited through an ERN ITHACA call for collaboration. 35 TRIP12 variants were identified, including frameshift (n = 15) and nonsense (n = 6) variants, as well as missense (n = 5) and splice (n = 3) variants, intragenic deletions (n = 4) and two multigene deletions disrupting TRIP12. Though variable in severity, global developmental delay was noted in all individuals, with language deficit most pronounced. About half showed autistic features and susceptibility to obesity seemed inherent to this disorder. A more severe expression was noted in individuals with a missense variant. Facial analysis showed a clear gestalt including deep-set eyes with narrow palpebral fissures and fullness of the upper eyelids, downturned corners of the mouth and large, often low-set ears with prominent earlobes. We report the largest cohort to date of individuals with TRIP12 variants, further delineating the associated phenotype and introducing a facial gestalt. These findings will improve future counseling and patient guidance.
U2 - 10.1038/s41431-023-01307-x
DO - 10.1038/s41431-023-01307-x
M3 - SCORING: Journal article
C2 - 36747006
VL - 31
SP - 461
EP - 468
JO - EUR J HUM GENET
JF - EUR J HUM GENET
SN - 1018-4813
IS - 4
ER -